NXXT
Next report

Nov 13 2026in 31 days

EPS estimate

($0.70)

Revenue estimate

$28M

EPS beats

5 of last 7

EPS surprise

2023: 4.9%2024: -35.4%2024: 20.7%2025: 76.0%2026: 66.7%2026: -21.5%2026: 33.3%
Nov 15 2023Aug 13 2026
ReportedEPS estEPS actualSurpriseRevenue estRevenue actualSurprise
Aug 13 2026($0.60)($0.40)+33.3%$24M$28M+18.0%
May 15 2026($0.60)($0.73)-21.5%$18M$21M+16.3%
Mar 26 2026($0.60)($0.20)+66.7%$24M$23M-2.5%
Nov 14 2025($0.50)($0.12)+76.0%$21M$23M+9.2%
Aug 14 2025—($0.30)——$20M—
May 20 2025—($1.60)—$16M$16M+3.0%
Mar 27 2025—($48.80)—$16M$28M+75.8%
Nov 13 2024—($19.50)—$14M$7M-50.8%
Aug 14 2024—($16.70)—$14M$7M-47.9%
May 14 2024($14.25)($11.30)+20.7%$14M$7M-51.8%
Apr 2 2024($14.25)($19.30)-35.4%$9M$6M-36.8%
Nov 15 2023($15.25)($14.50)+4.9%$8M$6M-17.8%

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+4.48%
EPS—
FY2028
Rev+13.89%
EPS—
FY2029
Rev+11.78%
EPS—
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028EFY2029EFY2030E
Revenue Avg$109M$114M$130M$146M$161M
Low$109M$114M$130M$146M$161M
High$109M$114M$130M$146M$161M
EBITDA Avg$-12M$-2M$7M$11M$15M
Low$-12M$-2M$7M$11M$15M
High$-12M$-2M$7M$11M$15M
EBIT Avg$-18M$-10M$-3M$-689,017$532,079
Low$-18M$-10M$-3M$-689,017$532,079
High$-18M$-10M$-3M$-689,017$532,079
Net Income Avg$-27M$-20M$-12M$-10M$-9M
Low$-27M$-20M$-12M$-10M$-9M
High$-27M$-20M$-12M$-10M$-9M
EPS Avg$-2.20$-1.60$-1.00$-0.80$-0.70
Low$-2.20$-1.60$-1.00$-0.80$-0.70
High$-2.20$-1.60$-1.00$-0.80$-0.70
Analysts (Rev / EPS)1 / 11 / 11 / 11 / 11 / 1
Quarterly
MetricQ4 2026
Revenue Avg$33M
Low$33M
High$33M
EBITDA Avg$-3M
Low$-3M
High$-3M
EBIT Avg$-4M
Low$-4M
High$-4M
Net Income Avg$-6M
Low$-6M
High$-6M
EPS Avg$-0.40
Low$-0.40
High$-0.40
Analysts (Rev / EPS)1 / 1
AI Earnings SummaryQ2 2026
Checking for summary...

Last reported Earnings history refreshes daily; a new report appears within about 2 daysAbout this data

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.